You are here

Clinical Trials: Eye Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Tuesday, December 20, 2022 - 12:00
Condition:   Myopic Chorioretinal Atrophy
Intervention:   Procedure: Pars plana vitrectomy
Sponsor:   PharmaBio Corporation
Not yet recruiting
Posted: Thursday, June 9, 2022 - 12:00
Condition:   Retinitis Pigmentosa
Interventions:   Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cells;   Biological: Subtenon injection of Wharton jelly derived mesenchymal stem cell exosomes;   Other: Placebo
Sponsor:   TC Erciyes University
Not yet recruiting
Posted: Tuesday, March 15, 2022 - 12:00
Conditions:   Ophthalmological Disorder;   Corneal Dystrophy;   Treatment;   Therapy;   Keratoconus
Interventions:   Procedure: Implantation;   Procedure: Lipoaspiration
Sponsors:   Vissum, Instituto Oftalmológico de Alicante;   Universidad Miguel Hernandez de Elche;   Instituto de Salud Carlos III
Not yet recruiting
Posted: Tuesday, January 11, 2022 - 12:00
Condition:   Age-Related Macular Degeneration
Interventions:   Biological: Cultured retinal stem and progenitor cells;   Other: Standard treatment according to the clinical protocols
Sponsors:   Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus;   Belarusian State Medical University
Not yet recruiting
Posted: Tuesday, December 7, 2021 - 12:00
Conditions:   Eye Diseases;   Retinitis Pigmentosa;   Glaucoma;   Diabetic Retinopathy;   Macular Degeneration;   Traumatic Optic Neuropathy;   Optic Atrophy
Intervention:   Biological: AlloRx
Sponsor:   The Foundation for Orthopaedics and Regenerative Medicine
Posted: Friday, October 1, 2021 - 12:00
Conditions:   Eye Health;   Age-related Macular Degeneration
Interventions:   Dietary Supplement: Freeze-dried table grape powder;   Dietary Supplement: Placebo of the table grape powder
Sponsors:   National University, Singapore;   National University Hospital, Singapore;   Ministry of Education, Singapore
Not yet recruiting
Posted: Friday, July 23, 2021 - 12:00
Conditions:   CLN3-related Disorders;   Low Vision
Intervention:   Device: OrCam MyEye 2
Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Posted: Monday, June 14, 2021 - 12:00
Condition:   Retinitis Pigmentosa
Intervention:   Biological: Intravitreal autologous CD34+ cells
Sponsors:   University of California, Davis;   Cures Within Reach
Posted: Thursday, May 6, 2021 - 12:00
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Friday, February 19, 2021 - 12:00
Condition:   Retinitis Pigmentosa (RP)
Interventions:   Biological: Injection of stem cells in sub-tenon space of eye for the management of retinitis pigmentosa;   Biological: Injection of stem cells in suprachoroidal space of eye for the management of Retinitis Pigmentosa
Sponsors:   Jinnah Burn and Reconstructive Surgery Centre, Lahore;   The Layton Rahmatullah Benevolent Trust (LRBT) Free Eye Hospital, Township Lahore.;   Centre of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore.